Serina Therapeutics (SER) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Serina Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $57K and 1 sold $501K of SER stock on the open market.
Get emailed when insiders cluster-buy stocks like SER
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
SER insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $2K | 1 | — | 0 |
| Q2 2026 | $76K | 6 | — | 0 |
| Q1 2026 | — | 0 | $230K | 10 |
| Q4 2025 | — | 0 | $272K | 19 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Serina Therapeutics, Inc. insiders reported open-market purchases totaling $57K, while 1 insider reported sales totaling $501K. 29 of 29 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 9SEC | Stephen K. BrannanDirector | Buy | 1,000new position | $2.03 | $2K | -1.5% | — |
| Jun 22SEC | Jay VenkatesanDirector | Buy | 589new position | $1.78 | $1K | +12.4% | — |
| Jun 15SEC | Karen J WilsonDirector | Buy | 5,100new position | $1.75 | $9K | +14.3% | — |
| Jun 15SEC | Karen J WilsonDirector | Buy | 5,00010,100 held (+98%) | $1.77 | $9K | +13.0% | — |
| May 26SEC | Karen J WilsonDirector | Buy | 10,00020,000 held (+100%) | $1.93 | $19K | +3.6% | — |
| May 26SEC | Karen J WilsonDirector | Buy | 10,000new position | $1.77 | $18K | +13.0% | — |
| May 22SEC | Richard Peter MarshallDirector | Buy | 12,183new position | $1.65 | $20K | +21.2% | — |
| Mar 24SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $2.86 | $19K | -30.1% | — |
| Mar 20SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 39,000 | $2.50 | $98K | -20.0% | — |
| Feb 3SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $3.03 | $20K | -34.0% | — |
| Jan 29SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $3.57 | $23K | -44.0% | — |
| Jan 23SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 2,500 | $2.95 | $7K | -32.2% | — |
| Jan 21SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 2,000 | $3.07 | $6K | -34.9% | — |
| Jan 21SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 2,000 | $3.00 | $6K | -33.3% | — |
| Jan 14SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 5,416 | $2.50 | $14K | -20.0% | — |
| Jan 14SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 1,084 | $2.50 | $3K | -20.0% | — |
| Jan 9SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 13,000 | $2.69 | $35K | -25.7% | — |
| Dec 29SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 4,100 | $2.60 | $11K | -23.1% | — |
| Dec 23SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 5,673 | $2.67 | $15K | -25.1% | — |
| Dec 17SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 3,227 | $2.96 | $10K | -32.4% | — |
| Dec 16SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 1,700 | $3.26 | $6K | -38.7% | — |
| Dec 12SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 3,555 | $3.24 | $12K | -38.3% | — |
| Dec 11SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 645 | $3.35 | $2K | -40.3% | — |
| Dec 11SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 600 | $3.31 | $2K | -39.6% | — |
| Dec 4SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 5,000 | $3.52 | $18K | -43.2% | — |
| Dec 4SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 1,500 | $3.91 | $6K | -48.8% | — |
| Nov 26SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 5,9655,965 held (−50%) | $3.90 | $23K | -48.7% | — |
| Nov 25SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 535 | $3.94 | $2K | -49.2% | — |
| Nov 19SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $3.75 | $24K | -46.7% | — |
| Nov 12SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $4.10 | $27K | -51.2% | — |
| Nov 6SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 3,398 | $4.24 | $14K | -52.8% | — |
| Nov 5SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 3,102 | $4.40 | $14K | -54.5% | — |
| Oct 29SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 5,551 | $4.96 | $28K | -59.7% | — |
| Oct 28SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 949 | $5.19 | $5K | -61.5% | — |
| Oct 21SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 6,500 | $4.97 | $32K | -59.8% | — |
| Oct 14SEC | Randall MoreadithChief Scientific Officer | Sell Plan | 4,326 | $5.20 | $22K | -61.5% | — |
Insiders at Serina Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Randall MoreadithChief Scientific Officer | — | $501K | Mar 24, 2026 | — |
| Karen J WilsonDirector | $55K | — | Jun 15, 2026 | — |
| Richard Peter MarshallDirector | $20K | — | May 22, 2026 | — |
| Stephen K. BrannanDirector | $2K | — | Jul 9, 2026 | — |
| Jay VenkatesanDirector | $1K | — | Jun 22, 2026 | — |
SER stock: common questions
Are Serina Therapeutics, Inc. insiders buying SER stock?
In the past 12 months, 2 insiders reported open-market purchases of SER worth $57K. The latest was Director Stephen K. Brannan bought $2K of SER at $2.03 — first open-market purchase in our records; opens a new position.
Are Serina Therapeutics, Inc. insiders selling SER stock?
1 insiders reported sales worth $501K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is SER's 52-week range?
Over the past year SER has traded between $1.28 and $5.58. It last closed at $2.00 on Oct 9, 2026.